Zimbabwe has declined a significant American health deal worth 367 million US dollars (£272m) spanning five years because of Washington's request for sensitive biological samples.
The decision was revealed after a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".
An official spokesperson later explained that the United States was seeking genetic material for research and profit while refused to guarantee the resulting advantages from future treatments.
"We will now turn to the difficult and regrettable task of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged further dialogue to secure a agreement suitable to all parties so the country's vital HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a court suspended a similar deal with the US after concerns were raised about the safety of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump stated its spending was "inefficient" and his government was seeking government-to-government deals to enhance openness and accountability.
According to reports, 16 African countries have to date agreed to these new health pacts, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation might have yielded significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to surrender its genetic material and health information over an extended period, without any corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that might result from that shared data," he stated.
"Put simply, our nation would provide the raw materials for medical research with no certainty that the final treatments would be accessible to our people if a new health crisis emerge."
National Interest and Global Health
He also noted that the US's withdrawal from the global health body and its push of one-on-one deals were disrupting structures previously established through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.
"This mechanism is intended to ensure that when a nation contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome further dialogue with our American counterparts on how subsequent co-operation might be arranged in a way that honours the independence and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that talks must proceed given that much of the country's Aids initiatives depended on foreign aid.
"If technical issues arise, such as those involving data governance or implementation frameworks, these can frequently be resolved through technical clarification and negotiated safeguards," the group said.
This impasse emphasises the continuing tensions between accepting crucial foreign assistance and protecting national sovereignty in an increasingly interconnected world.